{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:07:10Z","timestamp":1790150830913,"version":"4.0.1"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R366-2021-255"],"award-info":[{"award-number":["R366-2021-255"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24304-0"],"award-info":[{"award-number":["2017\/24304-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","award":["AUFF-E 2020-7-1 9"],"award-info":[{"award-number":["AUFF-E 2020-7-1 9"]}],"id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010809","name":"Jascha Foundation","doi-asserted-by":"publisher","award":["2023-0381"],"award-info":[{"award-number":["2023-0381"]}],"id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.phrs.2024.107545","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:24:46Z","timestamp":1733876686000},"page":"107545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression"],"prefix":"10.1016","volume":"211","author":[{"given":"Nicole R.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokouh","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana B.","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano M.","family":"Chaves-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Mottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Waszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H.","family":"Gobira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Nicola","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina H.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi K.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e2mia R.L.","family":"Joca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107545_bib1","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107545_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12888-018-1920-7","article-title":"Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study","volume":"18","author":"DiBernardo","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/appi.ajp.163.1.115","article-title":"Toward a comprehensive developmental model for major depression in men","volume":"163","author":"Kendler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110231","article-title":"Epigenetics: a missing link between early life stress and depression","volume":"109","author":"Juruena","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100896","article-title":"Do different types of stress differentially alter behavioural and neurobiological outcomes associated with depression in rodent models? A systematic review","volume":"61","author":"Du Preez","year":"2021","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.phrs.2024.107545_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.phrs.2024.107545_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1176\/appi.focus.140208","article-title":"Major depressive disorder: new clinical, neurobiological, and treatment perspectives","volume":"14","author":"Kupfer","year":"2016","journal-title":"Focus (Madison)"},{"key":"10.1016\/j.phrs.2024.107545_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","article-title":"Prevalence and clinical course of depression: a review","volume":"31","author":"Richards","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852921000791","article-title":"Novel antidepressant drugs: beyond monoamine targets","volume":"28","author":"Gonda","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.phrs.2024.107545_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","article-title":"Ketamine\u201450 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms","volume":"73","author":"Kohtala","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2024.107545_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.phrs.2024.107545_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2021.02.020","article-title":"Intranasal esketamine: from origins to future implications in treatment-resistant depression","volume":"137","author":"Sanders","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2024.107545_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109348","article-title":"Antidepressants in the post-ketamine Era: pharmacological approaches targeting the glutamatergic system","volume":"223","author":"Chaki","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107545_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41583-021-00540-x","article-title":"The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders","volume":"23","author":"Sanacora","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2019.02.017","article-title":"Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies","volume":"199","author":"Pham","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107545_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172837","article-title":"Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine","volume":"188","author":"Deyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2024.107545_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","article-title":"BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"38","author":"Kowia\u0144ski","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107545_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ijnp\/pyx116","article-title":"Role of 5-HT1A receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine","volume":"21","author":"Fukumoto","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00978","article-title":"S-ketamine mediates its acute and sustained antidepressant-like activity through a 5-HT1B receptor dependent mechanism in a genetic rat model of depression","volume":"8","author":"du Jardin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107545_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpain.2017.12.002","article-title":"The involvement of the endocannabinoid system in the peripheral antinociceptive action of ketamine","volume":"19","author":"Ferreira","year":"2018","journal-title":"J. Pain."},{"key":"10.1016\/j.phrs.2024.107545_bib25","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/s41467-020-19780-z","article-title":"Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107545_bib26","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.phrs.2024.107545_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpsychires.2019.10.010","article-title":"Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats","volume":"120","author":"Dong","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2024.107545_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuint.2019.01.023","article-title":"Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression","volume":"125","author":"Kirkedal","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2024.107545_bib29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2024.107545_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762738","article-title":"Reviewing the role of the endocannabinoid system in the pathophysiology of depression","volume":"12","author":"Gallego-Landin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib31","first-page":"435","article-title":"Role of the endocannabinoid system in the formation and development of depression","volume":"72","author":"Zhou","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.phrs.2024.107545_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2010.148","article-title":"Neuropsychiatric adverse effects signal the end of the line for rimonabant","volume":"7","author":"King","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2024.107545_bib33","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2174\/0929867328666210623144658","article-title":"Molecular targets of cannabinoids associated with depression","volume":"29","author":"Paudel","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107545_bib34","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.3390\/ijms23105526","article-title":"Modulation of endocannabinoid system components in depression: pre-clinical and clinical evidence","volume":"23","author":"Bright","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107545_bib35","series-title":"Cannabinoid Modulation of Emotion, Memory, and Motivation","first-page":"97","article-title":"Role of the endocannabinoid system in depression: from preclinical to clinical evidence","author":"Micale","year":"2015"},{"key":"10.1016\/j.phrs.2024.107545_bib36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ejn.15110","article-title":"Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation\/inhibition balance in health and disease","volume":"55","author":"Durieux","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.13595","article-title":"Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression","volume":"129","author":"Silveira","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2024.107545_bib38","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/s41467-020-19780-z","article-title":"Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107545_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/can.2022.0072","article-title":"CB1 receptor silencing attenuates ketamine-induced hyperlocomotion without compromising its antidepressant-like effects","volume":"8","author":"Gobira","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2024.107545_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1223145","article-title":"Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression","volume":"17","author":"Lullau","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00978","article-title":"S-Ketamine mediates its acute and sustained antidepressant-like activity through a 5-HT1B receptor dependent mechanism in a genetic rat model of depression","volume":"8","author":"du Jardin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib42","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","article-title":"The Flinders Sensitive Line rat: a selectively bred putative animal model of depression","volume":"29","author":"Overstreet","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression-25 years and still producing","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-clinpsy-072120-014126","article-title":"Ketamine and the future of rapid-acting antidepressants","volume":"17","author":"Riggs","year":"2021","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.phrs.2024.107545_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103484","article-title":"Scopolamine augmentation for depressive symptoms and cognitive functions in treatment-resistant depression: a case series","volume":"82","author":"Fang","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.phrs.2024.107545_bib46","article-title":"M2-AChR Mediates rapid antidepressant effects of scopolamine through activating the mTORC1-BDNF signaling pathway in the medial prefrontal cortex","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2024.107545_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0269881120959644","article-title":"Ketamine: a tale of two enantiomers","volume":"35","author":"Jelen","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.phrs.2024.107545_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 \u2013 January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107545_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121269","article-title":"Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2024.107545_bib52","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"du Jardin","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107545_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bph.13714","article-title":"Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus","volume":"174","author":"Ardalan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib54","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107545_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ijnp\/pyad016","article-title":"Sex and estrous cycle are not mediators of S-ketamine\u2019s rapid-antidepressant behavioral effects in a genetic rat model of depression","volume":"26","author":"Arjmand","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib56","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1007\/s12035-019-1613-3","article-title":"S-ketamine reverses hippocampal dendritic spine deficits in flinders sensitive line rats within 1h of administration","volume":"56","author":"Treccani","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107545_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109870","article-title":"Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression","volume":"248","author":"Domingos","year":"2024","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.phrs.2024.107545_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.phrs.2024.107545_bib59","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-0716-1916-2_7","article-title":"A guide to analysis of relative synaptic protein abundance by quantitative fluorescent western blotting","author":"M\u00fcller","year":"2022"},{"key":"10.1016\/j.phrs.2024.107545_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061379","article-title":"Male knock-in mice expressing an arachidonic acid lipoxygenase 15B (Alox15B) with humanized reaction specificity are prematurely growth arrested when aging","volume":"10","author":"Sch\u00e4fer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2024.107545_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148436","article-title":"Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson\u2019s disease","volume":"1814","author":"Binda","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2024.107545_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107545_bib63","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"Burley","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107545_bib64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107545_bib65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107545_bib66","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1016\/j.bmcl.2016.08.071","article-title":"Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors","volume":"26","author":"K\u00fchne","year":"2016","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.phrs.2024.107545_bib67","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1021\/acs.jmedchem.8b00824","article-title":"Design, Synthesis, and evaluation of piperazinyl pyrrolidin-2-ones as a novel series of reversible monoacylglycerol lipase inhibitors","volume":"61","author":"Aida","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2024.107545_bib68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107545_bib69","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1038\/s41467-020-18026-2","article-title":"Evidence that the TRPV1 S1-S4 membrane domain contributes to thermosensing","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107545_bib70","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107545_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.phrs.2024.107545_bib72","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.phrs.2024.107545_bib73","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.phrs.2024.107545_bib74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.phrs.2024.107545_bib75","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1073\/pnas.0806121105","article-title":"Structure-guided inhibitor design for human FAAH by interspecies active site conversion","volume":"105","author":"Mileni","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107545_bib76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature17964","article-title":"TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action","volume":"534","author":"Gao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107545_bib77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btr651","article-title":"FTSite: high accuracy detection of ligand binding sites on unbound protein structures","volume":"28","author":"Ngan","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2024.107545_bib78","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107545_bib79","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107545_bib80","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107545_bib81","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107545_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph"},{"key":"10.1016\/j.phrs.2024.107545_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.00456","article-title":"Repeated measures correlation","volume":"8","author":"Bakdash","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.phrs.2024.107545_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109646","article-title":"Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist\/inverse agonist rimonabant on fentanyl discrimination in male rats","volume":"240","author":"AlKhelb","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2024.107545_bib85","series-title":"Molecular Docking for Computer-Aided Drug Design","first-page":"75","article-title":"Best practices for docking-based virtual screening","author":"Neves","year":"2021"},{"key":"10.1016\/j.phrs.2024.107545_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107545_bib87","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107545_bib88","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejphar.2017.09.029","article-title":"Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats","volume":"815","author":"Silva Pereira","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib89","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuron.2019.12.024","article-title":"Endocannabinoid signaling collapse mediates stress-induced amygdalo-cortical strengthening","volume":"105","author":"Marcus","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107545_bib90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/mp.2010.131","article-title":"Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT\/MEK\/Arc signaling in restoration","volume":"17","author":"Eriksson","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib91","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/npp.2011.60","article-title":"Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the flinders sensitive line rat: a genetic rodent model of depression","volume":"36","author":"Hascup","year":"2011","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.phrs.2024.107545_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109870","article-title":"Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression","volume":"248","author":"Domingos","year":"2024","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.phrs.2024.107545_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2015.11.026","article-title":"Long-term characterization of the Flinders Sensitive Line rodent model of human depression: Behavioral and PET evidence of a dysfunctional entorhinal cortex","volume":"300","author":"Thiele","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2024.107545_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","volume":"8","author":"Bluett","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107545_bib95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pnpbp.2017.04.004","article-title":"Prefrontal endocannabinoids, stress controllability and resilience: a hypothesis","volume":"85","author":"Worley","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib96","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.euroneuro.2012.01.004","article-title":"Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway","volume":"22","author":"McLaughlin","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib97","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1017\/neu.2016.68","article-title":"A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats","volume":"29","author":"Kirkedal","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.phrs.2024.107545_bib98","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.neubiorev.2016.07.008","article-title":"Untangling the neurobiology of coping styles in rodents: towards neural mechanisms underlying individual differences in disease susceptibility","volume":"74","author":"de Boer","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0149-7634(97)00001-8","article-title":"Stress and emotionality: a multidimensional and genetic approach","volume":"22","author":"Ramos","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1450-z","article-title":"Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study","volume":"8","author":"Lindgren","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.phrs.2024.107545_bib101","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bph.15071","article-title":"Palmitoylethanolamide counteracts brain fog improving depressive-like behaviour in obese mice: possible role of synaptic plasticity and neurogenesis","volume":"178","author":"Lama","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib102","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-015-0139-5","article-title":"Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice","volume":"8","author":"Guida","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2024.107545_bib103","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2024.107545_bib104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","article-title":"Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures","volume":"26","author":"Smaga","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2024.107545_bib105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","article-title":"Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures","volume":"26","author":"Smaga","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2024.107545_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104635","article-title":"Rapid treatments for depression: endocannabinoid system as a therapeutic target","volume":"137","author":"Sharafi","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib107","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1007\/s00210-023-02938-z","article-title":"How depression and antidepressant drugs affect endocannabinoid system?\u2014review of clinical and preclinical studies","volume":"397","author":"Dragon","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6651492","article-title":"Chronic inhibition of FAAH reduces depressive-like behavior and improves dentate gyrus proliferation after chronic unpredictable stress exposure","volume":"2021","author":"Tejeda-Mart\u00ednez","year":"2021","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.phrs.2024.107545_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762738","article-title":"Reviewing the role of the endocannabinoid system in the pathophysiology of depression","volume":"12","author":"Gallego-Landin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib110","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.3390\/ijms23105526","article-title":"Modulation of endocannabinoid system components in depression: pre-clinical and clinical evidence","volume":"23","author":"Bright","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107545_bib111","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.euroneuro.2012.01.004","article-title":"Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway","volume":"22","author":"McLaughlin","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib112","doi-asserted-by":"crossref","first-page":"13369","DOI":"10.1523\/JNEUROSCI.4867-07.2007","article-title":"Serotonin, the prefrontal cortex, and the antidepressant-like effect of cannabinoids","volume":"27","author":"Moreira","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib113","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3219490","article-title":"Ketamine administration reverses corticosterone-induced alterations in excitatory and inhibitory transmission in the rat dorsal raphe nucleus","volume":"2019","author":"Sowa","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.phrs.2024.107545_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/genes13112165","article-title":"Regulation of DNA methylation by cannabidiol and its implications for psychiatry: new insights from in vivo and in silico models","volume":"13","author":"Domingos","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.phrs.2024.107545_bib116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/med.21418","article-title":"Allosteric modulation: an alternate approach targeting the cannabinoid CB1 receptor","volume":"37","author":"Nguyen","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2024.107545_bib117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuro.2017.08.012","article-title":"Changes in the cannabinoids receptors in rats following treatment with antidepressants","volume":"63","author":"Smaga","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.phrs.2024.107545_bib118","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","article-title":"The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets","volume":"12","author":"Bambico","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phrs.2024.107545_bib119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107545_bib120","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2024.107545_bib121","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107545_bib122","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/ejn.12561","article-title":"Cannabinoid receptor type 1 receptors on <scp>GABA<\/scp> ergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice","volume":"40","author":"Terzian","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112697","article-title":"Behavioral assessment of rimonabant under acute and chronic conditions","volume":"390","author":"Ettaro","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2024.107545_bib124","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":"Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents","volume":"57","author":"Griebel","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107545_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031047","article-title":"Molecular sciences elevated brain fatty acid amide hydrolase induces depressive-like phenotypes in rodent models: a review","author":"Rafiei","year":"2021","journal-title":"Rev. Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107545_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00235","article-title":"Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability","volume":"9","author":"H\u00e4ring","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib127","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib128","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","article-title":"Modulation of the serotonin system by endocannabinoid signaling","volume":"61","author":"Haj-Dahmane","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107545_bib129","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acschemneuro.9b00288","article-title":"Role of serotonin and noradrenaline in the rapid antidepressant action of ketamine","volume":"10","author":"L\u00f3pez-Gil","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107545_bib130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ijnp\/pyx116","article-title":"Role of 5-HT1A receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine","volume":"21","author":"Fukumoto","year":"2018","journal-title":"Int. Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107545_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2013.03.043","article-title":"Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain","volume":"709","author":"Ortega","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:47:53Z","timestamp":1736430473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":131,"alternative-id":["S1043661824004900"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107545","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107545"}}